Analysts are maintaining a cautious stance on Raffles Medical Group following the announcement of its 1H2020 results on July 27.

In what RHB analyst Juliana Cai deems “results infected by Covid-19”, the group posted a 38.2% drop in earnings to $17.2 million. This comes on the back of a deferment in elective surgeries and a dip in foreign patients, particularly during the circuit breaker period in Singapore.

In China, the group was hit by a smaller patient load at its RafflesHospital Chongqing as well as the closure of clinics due to the movement restrictions imposed there.

To continue reading,

Sign in to access this Premium article.

Subscription entitlements:

Less than $9 per month
3 Simultaneous logins across all devices
Unlimited access to latest and premium articles
Bonus unlimited access to online articles and virtual newspaper on The Edge Malaysia (single login)

Stay updated with Singapore corporate news stories for FREE

Follow our Telegram | Facebook